Akebia Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 2 178 208 335 295 214 293 195 160
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% inf% 11495.0% 16.7% 61.3% -11.8% -27.7% 37.0% -33.5% -17.7%
Marża brutto 0.0% 0.0% 0.0% 0.0% 100.0% 100.0% 96.3% 56.6% -0.2% 28.2% 71.0% 61.1% 60.6%
EBIT (mln) -9 -16 -38 -62 -136 -80 -178 -286 -376 -265 -63 -46 -50
EBIT Δ r/r 0.0% 86.9% 138.1% 62.1% 121.8% -41.4% 122.9% 60.7% 31.5% -29.5% -76.2% -27.1% 9.5%
EBIT (%) 0.0% 0.0% 0.0% 0.0% -8889.9% -44.9% -85.8% -85.5% -127.5% -124.2% -21.6% -23.7% -31.5%
Koszty finansowe (mln) -2 1 0 1 0 0 6 1 -9 -20 16 6 18
EBITDA (mln) -9 -15 -38 -61 -136 -79 -178 -286 -376 -265 -46 -4 -14
EBITDA(%) 0.0% 0.0% 0.0% 0.0% -8870.6% -44.6% -85.8% -85.5% -127.5% -124.2% -15.8% -2.2% -8.6%
Podatek (mln) 0 2 -0 -1 -1 -3 -28 -7 -34 -38 13 0 0
Zysk Netto (mln) -8 -13 -37 -61 -136 -77 -172 -280 -350 -245 -106 -52 -69
Zysk netto Δ r/r 0.0% 60.7% 181.3% 63.9% 123.6% -43.3% 123.5% 62.7% 25.1% -30.0% -56.7% -51.0% 33.7%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% -8843.5% -43.2% -82.7% -83.5% -118.5% -114.7% -36.2% -26.7% -43.3%
EPS -0.81 -0.68 -2.4 -2.29 -3.6 -1.77 -1.47 -2.36 -2.53 -1.48 -0.58 -0.28 -0.33
EPS (rozwodnione) -0.81 -0.68 -2.4 -2.29 -3.6 -1.77 -1.47 -2.36 -2.53 -1.48 -0.58 -0.28 -0.33
Ilośc akcji (mln) 10 19 15 26 38 44 117 118 138 166 183 187 211
Ważona ilośc akcji (mln) 10 19 15 26 38 44 117 118 138 166 183 187 211
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD